Stereotactic radiotherapy as an alternative to surgical treatment at the early stage of non‑small cell lung cancer
01/2019
MUDr. Stanislav Hloušek; doc. MUDr. Milada Zemanová, Ph.D.; prof. MUDr. David Feltl, Ph.D., MBA
Onkologická klinika 1. LF UK a VFN, Praha
SUMMARY
Case presents a patient with non-small cell lung cancer at clinical stage IA3, who refused surgical removal of the tumor. Instead of surgery, the patient was offered a variant with stereotactic radiotherapy that the patient agreed to and underwent without complications. Partial remission was observed in subsequent CT scans. One year after the therapy the patient is without signs of progression or generalization. The case therefore presents an alternative to standard surgical treatment for patients for whom, for various reasons, this modality is not indicated or preferred.
KEY WORDS
stereotactic radiotherapy, non-small cell lung cancer, early stage
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...